Stevens Capital Management LP Gilead Sciences, Inc. Transaction History

Stevens Capital Management LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $944,569 - $1.15 Million	13,196 New	13,196 $967,000
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $845,655 - $952,461	-14,651 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $848,585 - $1.06 Million	14,651 New	14,651 $871,000
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $765,130 - $836,014	-12,055 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $723,300 - $825,285	12,055 New	12,055 $779,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $3.83 Million - $4.81 Million	-61,626 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $4.46 Million - $5.18 Million	61,626 New	61,626 $4.74 Million
Q1 2020 Apr 21, 2020	SELL	$62.63 - $80.22 $2.6 Million - $3.33 Million	-41,465 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$61.62 - $67.78 $4.16 Million - $4.57 Million	-67,458 Reduced 61.93%	41,465 $2.69 Million
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $3.05 Million - $3.37 Million	-48,795 Reduced 30.94%	108,923 $6.9 Million
Q2 2019 Jul 31, 2019	SELL	$61.87 - $69.38 $108,086 - $121,206	-1,747 Reduced 1.1%	157,718 $10.7 Million
Q1 2019 May 03, 2019	BUY	$62.53 - $70.05 $3.18 Million - $3.56 Million	50,892 Added 46.87%	159,465 $10.4 Million
Q4 2018 Feb 06, 2019	BUY	$60.54 - $79.0 $6.57 Million - $8.58 Million	108,573 New	108,573 $6.79 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.